Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;8(2):299–324. doi: 10.1111/j.1750-3639.1998.tb00156.x

Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?

Paul G Ince 1,2,✉, Elaine K Perry 1, Chris M Morris 1
PMCID: PMC8098421  PMID: 9546289

Abstract

Lewy body formation is central to the pathological phenotype of a spectrum of disorders. The most familiar of these is the extrapyramidal syndrome of idiopathic Lewy‐body Parkinson's disease (PD). Studies of dementia in the elderly suggest that another manifestation of Lewy body pathology is equally or more common than Parkinson's disease. This syndrome of Dementia with Lewy bodies (DLB) has been given a number of diagnostic labels and is characterised by dementia, relatively mild parkinsonism, visual hallucinations, and fluctuations in conscious level. Although many of these features can arise in Parkinson's disease, the patients with DLB tend to have early neuropsychiatric features which predominate the clinical picture, and the diagnosis of the syndrome in practice is more concerned with the differential diagnosis of Alzheimer's disease (AD). Distinction from AD has clinical importance because of potentially differing therapeutic implications. Diagnostic guidelines for the clinical diagnosis and pathological evaluation of DLB are reviewed. Research into the disorder has centered around characterising the clinical, neuropsychological, pathological, neurochemical and genetic relationships with Alzheimer's disease on the one hand, and Parkinson's disease on the other. Many cases of DLB have prominent pathological features of AD and there are some shared genetic risk factors. Differences from the pathology of PD are predominantly quantitative rather than qualitative and evidence is discussed which suggests that DLB represents a clinicopathological syndrome within the spectrum of Lewy body disorders. The possibility that the syndrome represents a chance association of PD and AD is not supported by published studies.

Full Text

The Full Text of this article is available as a PDF (325.6 KB).

References

  • 1. Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337:1321–4. [DOI] [PubMed] [Google Scholar]
  • 2. Agundez JA, Jimenez‐Jimenez FJ, Luengo A, Bernal ML, Molina JA, Ayuso L, Vazquez A, Parra J, Duarte J, Coria F (1995) Association between the oxidative polymorphism and early onset of Parkinson's dsiease. Clin Pharmacol Therap 57:291–8. [DOI] [PubMed] [Google Scholar]
  • 3. Ala TA, Yang KH, Sung JH, Frey WH (1997) Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatr 62:16–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Alvord EC, Forno LS, Kusske JA, Kauffman RJ, Rhodes JS, Goetowski CR (1974) The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brain stem. Adv Neurol 5:175–93. [PubMed] [Google Scholar]
  • 5. Arai H, Lee VM‐Y, Hill WD, Greenberg BD, Trojanowski JQ (1992) Lewy bodies contain beta‐amyloid precursor proteins of Alzheimer's disease. Brain Res 585:386–90. [DOI] [PubMed] [Google Scholar]
  • 6. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339:1017–8. [DOI] [PubMed] [Google Scholar]
  • 7. Armstrong RA, Cairns NJ, Lantos PL (1997) Beta‐Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 227:193–6. [DOI] [PubMed] [Google Scholar]
  • 8. Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1:103–16. [DOI] [PubMed] [Google Scholar]
  • 9. Bancher C, Lassmann H, Budka H, Jellinger K, Grunde‐Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81–93. [DOI] [PubMed] [Google Scholar]
  • 10. Bandmann O, Sweeney MG, Daniel SE, Marsden CD, Wood NW (1997) Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol 244:262–5. [DOI] [PubMed] [Google Scholar]
  • 11. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW (1997) Association of slow acetylator genotype for N‐acetyltransferase 2 with familial Parkinson's disease. Lancet 350:1136–9. [DOI] [PubMed] [Google Scholar]
  • 12. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM (1994) Apolipoprotein E genes in Lewy body and Parkinson's diseases. Lancet 343:1565. [DOI] [PubMed] [Google Scholar]
  • 13. Benjamin R, Leake A, Ince PG, Perry RH, McKeith IG, Edwardson JA, Morris CM (1995) Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body type and Alzheimer's disease. Neurodegeneration 4:443–8. [DOI] [PubMed] [Google Scholar]
  • 14. Bergem ALM (1994) Heredity in dementia of the Alzheimer type. Clin Genet 46:144–9. [DOI] [PubMed] [Google Scholar]
  • 15. Bergeron C, Petrunka C, Weyer L, Pollanen MS (1996) Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol 148:1267–72. [PMC free article] [PubMed] [Google Scholar]
  • 16. Bergeron C, Pollanen MS (1989) Lewy bodies in Alzheimer's disease. One or two diseases Alz Dis Assoc Disord 3:197–204. [PubMed] [Google Scholar]
  • 17. Bodhireddy S, Dickson DW, Mattiace L, Weidenheim KM (1994) A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease. Neurology 44:159–61. [DOI] [PubMed] [Google Scholar]
  • 18. Boller E, Mizutani T, Roessmann U, Gambetti P (1980) Parkinson's disease, dementia and Alzheimer's disease: clinicopathological correlations. Ann Neurol 7:329–35. [DOI] [PubMed] [Google Scholar]
  • 19. Bordet R, Broly F, Destee A, Libersa C (1994) Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinon's disease and diffuse Lewy body disease. Clin Pharmacol 17:484–8. [DOI] [PubMed] [Google Scholar]
  • 20. Bordet R, Broly F, Destee A, Libersa C, Lafitte JJ (1996) Lack of a relation between genetic polymorphism of cytochrome P‐450IID6 and sporadic idiopathic Parkinson's disease. Clin Neuropharmacol 19:213–21. [DOI] [PubMed] [Google Scholar]
  • 21. Braak H, Braak E (1991) Neuropathological staging of Alzheimer‐related changes. Acta Neuropathol 82:239–59. [DOI] [PubMed] [Google Scholar]
  • 22. Braak H, Braak E, Yilmazer D, de Vos R, Jansen EN, Bohl J (1995) Nigral and extranigral pathology in Parkinson's disease. J Neural Trans 46 (Suppl): 15–31. [PubMed] [Google Scholar]
  • 23. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EH, Bohl J, Jellinger KA (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88:493–500. [DOI] [PubMed] [Google Scholar]
  • 24. Breitner JCS, Welsh KA, Gau BA, McDonald WM, Steffens DC, Saunders AM, Magruder KM, Helms MJ, Plassman BL, Folstein MF (1995) Alzheimer's disease in the National Academy of Sciences‐National Research Council Registry of aging twin veterans. III. Detection of cases, longtitudinal results and observations on twin concordance. Arch Neurology 52:763–71. [DOI] [PubMed] [Google Scholar]
  • 25. Breitner JCS, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak‐Vance MA, Saunders AM (1995) Delayed onset of Alzheimer's disease with non‐steroidal anti‐inflammatory and histamine H2‐blocking drugs. Neurobiol Aging 16:523–30. [DOI] [PubMed] [Google Scholar]
  • 26. Brion JP, Couck AM (1995) Cortical and brainstem‐type Lewy bodies are immunoreactive for the cyclin‐dependent kinase 5. Am J Pathol 147:1465–76. [PMC free article] [PubMed] [Google Scholar]
  • 27. Brookes A. J., Howell WM, Woodburn K, Johnstone EC, Carothers A (1997) Presenilin‐I, presenilin‐II, and VLDL‐R associations in early onset Alzheimer's disease. Lancet 350:336–7. [DOI] [PubMed] [Google Scholar]
  • 28. Burkhardt CR, Filet CM, Kleinschmidt‐DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38:1520–8. [DOI] [PubMed] [Google Scholar]
  • 29. Byrne EJ, Lennox G, Godwin‐Austen RB, et al (1991) Dementia associated with cortical Lewy bodies: proposed clinical diagnostic criteria. Dementia 2:283–4. [Google Scholar]
  • 30. Byrne EJ, Lennox G, Louin J, Godwin Austen RB (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatr 52:709–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Cammarata S, Caponnetto C, Tabaton M (1993) Ubiquitin‐reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia Neurosci Lett 156:96–8. [DOI] [PubMed] [Google Scholar]
  • 32. Campion D, Martin C, Heilig R, Charbonner F, Moreau V, Flaman JM, Petit JL, Hannequin D, Brice A, Frebourg T (1995) The NACP/synuclein gene: Chromosomal assignment and screening for alterations in Alzheimer's disease. Genomics 26:254–7. [DOI] [PubMed] [Google Scholar]
  • 33. Castano EM, Prelli F, Wisinewski T, Golabek A, Kumar RA, Soto C, Frangione B (1995) Fibrillogenesis in Alzheimer's disease of the amyloid b peptides and apolipoprotein E . Biochem J 306:599–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Chin SS‐M, Goldman JE (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurobiol 55:499–508. [DOI] [PubMed] [Google Scholar]
  • 35. Clinton J, Blackman SE‐A, Royston MC, Roberts GW (1994) Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material. Neuroreport 5:497–500. [DOI] [PubMed] [Google Scholar]
  • 36. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak‐Vance MA (1993) Gene dose effect of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921–3. [DOI] [PubMed] [Google Scholar]
  • 37. Costa P, Checkoway H, Levy D, Smith‐Weller T, Franklin GM, Swanson PD, Costa LG (1997) Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson's disease. Am J Med Genet 74:154–6. [DOI] [PubMed] [Google Scholar]
  • 38. Court JA, Perry EK (1994) CNS nicotinic receptors: the therapeutic target in neurodegeneration. CNS Drugs 2:216–33. [Google Scholar]
  • 39. Cummings J (1997) Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer's disease. Alz Dis Assoc Disord 11:51–9. [PubMed] [Google Scholar]
  • 40. Curran M, Middelton D, Edwardson JA, Perry RH, McKeith IG, Morris CM, Neill D (1997) HLA‐DR antigens are associated with major genetic risk for late‐onset Alzheimer's disease. Neuroreport 8:1467–9. [DOI] [PubMed] [Google Scholar]
  • 41. Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN (1992) Relationship between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol 83:525–9. [DOI] [PubMed] [Google Scholar]
  • 42. Davis RE, Miller S, Hernstadt C, Ghosh SS, Fahy E, Shinobu LA. D. G. Thai LJ, Beal MF, Howell N, Parker WDJ (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late‐onset Alzheimer disease. Proc Natl Acad Sci USA 94:4526–31. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 43. de la Monte SM, Ng SC, Hsu DW (1995) Aberrant GAP‐43 gene expression in Alzheimer's disease. Am J Pathol 147:934–46. [PMC free article] [PubMed] [Google Scholar]
  • 44. de Michele G, Filla A, Marconi R, Volpe G, D'Alessio A, Scala R, Ambrosio G, Campanella G (1995) A genetic study of Parkinson's disease. J Neural Trans 45(Suppl):21–5. [PubMed] [Google Scholar]
  • 45. de Vos RA, Jansen EN, Stam FC, Ravid R, Swaab DF (1995) ‘Lewy Body Disease’: clinicopatholgical correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22. [DOI] [PubMed] [Google Scholar]
  • 46. Defendini R, Markesbury W, Mastri A, Duffy P (1973) Hallervorden‐spatz disease and infantile neuraxonal dystrophy. J Neurol Sci 20:7–23. [DOI] [PubMed] [Google Scholar]
  • 47. DeLeon G, Grover W, Huff D (1976) Neuropathological changes in ataxia telangiectasia. Neurology 26:947–51. [DOI] [PubMed] [Google Scholar]
  • 48. Den Hartog Jager WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomie nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatr 23:283–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Denk H, Eckerstorfer R, Gschnait F, Konrad K, Wolff K (1976) Experimental induction of hepatocellular hyaline (Mallory bodies) in mice by griseofulvin treatment: 1. Light microscopic observations. Lab Invest 35:377–82. [PubMed] [Google Scholar]
  • 50. DeWitt DA, Richey PL, Silver J, Perry G (1994) Chondroitin sulphate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res 656:205–9. [DOI] [PubMed] [Google Scholar]
  • 51. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak‐Reding H, Davies P, Yen S‐HC (1989) Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 78:572–84. [DOI] [PubMed] [Google Scholar]
  • 52. Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE (1987) Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathol 75:8–15. [DOI] [PubMed] [Google Scholar]
  • 53. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S‐H (1991) Hippocampal degeneration differentiates diffuse Lewy body disaese (DLBD) from Alzheimer's disease. Neurology 41:1402–9. [DOI] [PubMed] [Google Scholar]
  • 54. Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JC (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87:269–76. [DOI] [PubMed] [Google Scholar]
  • 55. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990–3. [DOI] [PubMed] [Google Scholar]
  • 56. Ditter SM, Mirra SS (1987) Neuropathological and clinical features of Parkinson's disease patients. Neurology 37:754–60. [DOI] [PubMed] [Google Scholar]
  • 57. Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G (1997) Brain perfusion scintigraphy with 99mTc‐HMPAO or 99mTc‐ECD and 1231‐beta‐CIT single‐photon emission tomography in dementia of the Alzheimer‐type and diffuse Lewy body disease. Eur J Nucl Med 24:320–5. [DOI] [PubMed] [Google Scholar]
  • 58. Dooling E, Schoene W, Richardson E (1974) Hallervorden‐Spatz syndrome. Arch Neurol 30:70–83. [DOI] [PubMed] [Google Scholar]
  • 59. Drach LM, Steinmetz HE, Wach S, Bohl J (1997) High proportion of dementia with Lewy bodies in the postmortems of a mental hospital in Germany. Int J Geriat Psychiat 12:301–6. [PubMed] [Google Scholar]
  • 60. Duvoisin RC, Johnson WG (1992) Hereditary Lewy‐body parkinsonism and evidence for a genetic etiology of Parkinson's disease. Brain Pathol 2:309–20. [DOI] [PubMed] [Google Scholar]
  • 61. Egensperger R, Kosel S, Schnopp NM, Mehraein P, Graeber MB (1997) Association of the mitochondrial tRNA (A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol Appl Neurobiol 23:315–21. [PubMed] [Google Scholar]
  • 62. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers R, Pericak‐Vance MA, Risch N, van Duijn CN (1997) Effects of age sex and ethnicity on the association between Apolipoprotein E genotype and Alzheimer's disease. A meta‐analysis. JAMA 278:1349–56. [PubMed] [Google Scholar]
  • 63. Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 55:53–67. [DOI] [PubMed] [Google Scholar]
  • 64. Fergusson J, Landon M, Lowe J, Dawson SP, Layfield R, Hanger DP, Mayer R.J. (1996) Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci Lett 219:167–70. [DOI] [PubMed] [Google Scholar]
  • 65. Forno LS (1982) Pathology of Parkinson's disease. In: Movement Disorders, Marsden CD, Fahn S, (Eds.), pp. 25–40, Butterworth: London . [Google Scholar]
  • 66. Forno LS, Barbour PJ, Norville RL (1978) Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 35:818–22. [DOI] [PubMed] [Google Scholar]
  • 67. Forno LS, Sternberger L, Sternberger N, Strefling A, Swanson K, Eng L (1986) Reaction of Lewy bodies with antibodies to phophorylated and non‐phosphorylated neurofilaments. Neurosci Lett 64:253–8. [DOI] [PubMed] [Google Scholar]
  • 68. Forstl H, Burns A, Luthert P, Cairns N, Levy R (1993) The lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatr 162:385–92. [DOI] [PubMed] [Google Scholar]
  • 69. Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin‐positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118:1447–59. [DOI] [PubMed] [Google Scholar]
  • 70. Gai WP, Blumbergs PC, Blessing WW (1996) Microtubule‐associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 91:78–81. [DOI] [PubMed] [Google Scholar]
  • 71. Galasko D, Katzman R, Salmon DP, Hansen L (1996) Clinical features and neuropathological findings in Lewy body dementias. Brain Cognition 31:166–75. [DOI] [PubMed] [Google Scholar]
  • 72. Galasko D, Salmon DP, Thai LJ (1996) The nosological status of Lewy body dementia. In: Dementia with Lewy bodies, Perry RH, McKeith IG, Perry EK, (Eds.), pp. 21–32, Cambridge University Press: Cambridge . [Google Scholar]
  • 73. Galloway P, Grunde‐lqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer's neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–63. [DOI] [PubMed] [Google Scholar]
  • 74. Galloway PH, Sahgal A, McKeith IG, et al (1992) Visual pattern recognition memory and learning deficits in senile dementias of Alzheimer and Lewy body types. Dementia 3:101–7. [Google Scholar]
  • 75. Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol 64:43–52. [DOI] [PubMed] [Google Scholar]
  • 76. Gaytan‐Garcia S, Kaufmann JC, Young G (1990) Adult onset Hallervorden‐Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? a clinicopathological study. Clin Neuropathol 9:136–42. [PubMed] [Google Scholar]
  • 77. Gentleman SM, Williams B, Royston MC, Jagoe R, Clinton J, Perry RH, Ince PG, Allsop D, Polak JM, Roberts GW (1992) Quantification of ßA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of Lewy body type. Neurosci Left 142:9–12. [DOI] [PubMed] [Google Scholar]
  • 78. Gibb WRG (1986) Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 12:223–34. [DOI] [PubMed] [Google Scholar]
  • 79. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15:27–44. [DOI] [PubMed] [Google Scholar]
  • 80. Gibb WRG, Scaravilli F, Michaud J (1990) Lewy bodies and subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatr 53:710–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Golbe LI (1993) The genetics of Parkinson's disease. Rev Neurosci 4:1–16. [DOI] [PubMed] [Google Scholar]
  • 82. Goldman J, Yne S‐H, Chiu F, Peress N (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–4. [DOI] [PubMed] [Google Scholar]
  • 83. Graham C, Ballard C, Saad K (1997) Variables which distinguish patients fulfilling clinical criteria for dementia with Lewy bodies from those with Alzheimer's disease. Int J Geriatr Psychiatr 12:314–8. [PubMed] [Google Scholar]
  • 84. Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomie failure: autopsy findings and review of the literature. Acta Neuropathol 94:192–6. [DOI] [PubMed] [Google Scholar]
  • 85. Hakim AM, Mathieson G (1979) Dementia in Parkinson's disease: a neuropathologic study. Neurology 29:1209–14. [DOI] [PubMed] [Google Scholar]
  • 86. Halliday G, Brooks W, Arthur H, Creasey H, Broe GA (1997) Further evidence for an association between a mutation in the APP gene and Lewy body formation. Neurosci Lett 227:49–52. [DOI] [PubMed] [Google Scholar]
  • 87. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, de Teresa R, Thai L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 40:1–8. [DOI] [PubMed] [Google Scholar]
  • 88. Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78:194–201. [DOI] [PubMed] [Google Scholar]
  • 89. Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque‐only Alzheimer's disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52:648–54. [DOI] [PubMed] [Google Scholar]
  • 90. Hansen LA, Samuel W (1997) Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 48:126–32. [DOI] [PubMed] [Google Scholar]
  • 91. Harrington CR, Louwagie J, Rossau R, Vanmechlen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 145:1472–84. [PMC free article] [PubMed] [Google Scholar]
  • 92. Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, Wischik CM (1994) Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia 5:216–28. [DOI] [PubMed] [Google Scholar]
  • 93. Hedera P, Lerner AJ, Castellani R, Freiland RP (1995) Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease and amyotrophic lateral sclerosis. J Neurol Sci 128:219–24. [DOI] [PubMed] [Google Scholar]
  • 94. Helfand M (1935) Status pigmentatus: its pathology and relation to Hallervorden‐Spatz disease. J Nerv Mental Disord 81:662–75. [Google Scholar]
  • 95. Herbert LE, Scherr PA, Beckett LA, Albert MS, Rosner B, Taylor JO, Evans DA, (1992) Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 135:347–55. [DOI] [PubMed] [Google Scholar]
  • 96. Hill WD, Lee VM‐Y, Hurtig HI, Murrat JM, Trojanowski JQ (1991) Epitopes located in spatially separated domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies. J Comp Neurol 309:150–60. [DOI] [PubMed] [Google Scholar]
  • 97. Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, Al‐Chalabi A, Kunugi H, Vallada H, Leigh PN (1996) No association between Parkinson's disease and low‐activity alleles of catechol O‐methyltransferase. Biochem Biophys Res Commun 228:780–4. [DOI] [PubMed] [Google Scholar]
  • 98. Horoupian D, Chu P (1994) Unusual case of corticobasal degeneration with tau/Gallyas‐positive neuronal and glial tangles. Acta Neuropathol 82:592–8. [DOI] [PubMed] [Google Scholar]
  • 99. Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C, Trofatter J, Baenziger J, Diamond S, Markham C, Sullivan J (1994) Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 9:305–10. [DOI] [PubMed] [Google Scholar]
  • 100. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol 50:140–8. [DOI] [PubMed] [Google Scholar]
  • 101. Hutchinson M, Fazzini E (1996) Cholinesterase inhibition in Parkinson's disease. J Neurol Neurosurg Psychiatr 61:324–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Hyman BT, Gomez‐lsla T, West H, Briggs M, Chung H, Growden JH, Rebeck GW (1996) Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann NY Acad Sci 777:158–65. [DOI] [PubMed] [Google Scholar]
  • 103. Ii K, Ito H, Tanaka K, Hirano A (1997) Immunocytochemical co‐localisation of the proteasome in ubiquitinated structures in neurodegenerative disease and the elderly. J Neuropathol Exp Neurol 56:125–31. [DOI] [PubMed] [Google Scholar]
  • 104. Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non‐demented elderly control patients. J Neurol Sci 106:142–52. [DOI] [PubMed] [Google Scholar]
  • 105. Ince PG, Jaros E, Ballard C, McKeith IG, Perry RH (1998) Prospective evaluation of consensus diagnosis criteria for Dementia with Lewy bodies. Neuropathol Appl Neurobiol 24:in press. [Google Scholar]
  • 106. Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease and vascular lesions. Dementia 6:162–8. [DOI] [PubMed] [Google Scholar]
  • 107. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT (1996) Characterization of the precursor protein of the non‐A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889–95. [DOI] [PubMed] [Google Scholar]
  • 108. Iseki E, Li F, Kosaka K (1997) Close relationship between spongiform change and ubiquitin‐positive granular structures in dffuse Lewy body disease. J Neurol Sci 146:53–7. [DOI] [PubMed] [Google Scholar]
  • 109. Iseki E, Odawara T, Kosaka K, Akiyama H, Ikeda K (1995) Incidence and distribution of Lewy bodies and senile changes in the amygdala in diffuse Lewy body disease (DLBD) brains. Brain Pathol 4:533. [Google Scholar]
  • 110. Iseki E, Odawara T, Li F, Kosaka K, Nishimura T, Akiyama H, Ikeda K (1996) Age‐related ubiquitin‐positive granular structures in non‐demented subjects and neurodegenerative disorders. J Neurol Sci 142:25–9. [DOI] [PubMed] [Google Scholar]
  • 111. Ishikawa A, Takahashi H, Tanaka H, Hayashi T, Tsuji S (1997) Clinical features of familial diffuse Lewy body disease. Eur Neurol 38 (Suppl):34–8. [DOI] [PubMed] [Google Scholar]
  • 112. Itoh K, Weis S, Mehraein P, Muller‐Hocker J (1997) Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: an immunohistochemical and morphometric study. Mov Disord 12:9–16. [DOI] [PubMed] [Google Scholar]
  • 113. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T (1995) The precursor protein of non‐A beta component of Alzheimer's disease is a preesynaptic protein of the central nervous system. Neuron 14:467–75. [DOI] [PubMed] [Google Scholar]
  • 114. Iwatsubo T, Nakano I, Fukunaga K, Miyamoto E (1991) Ca2+/calmodulin dependent protein kinase II immunoreactivity in Lewy bodies. Acta Neuropathol 82:159–63. [DOI] [PubMed] [Google Scholar]
  • 115. Iwatsubo T, Yamaguchi H, Fujimoro M, Yokosawa H, Ihara Y, Trojanowski JC, Lee VM‐Y (1996) Purification and characterisation of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148:1517–29. [PMC free article] [PubMed] [Google Scholar]
  • 116. Jackson M, Gentlemen S, Lennox G, Ward L, Church R, Randall K, Lowe J (1995) The cortical neuritic pathology of Huntington's disease. Neuropathol Applied Neurobiol 21:18–26. [DOI] [PubMed] [Google Scholar]
  • 117. Jackson M, Lennox G, Balsitis M, Lowe J (1995) Lewy body dysphagia. J Neurol Neurosurg Psychiatr 58:756–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Jackson M, Lennox G, Lowe J (1996) Motor neurone disease‐inclusion dementia. Neurodegeneration 5:339–50. [DOI] [PubMed] [Google Scholar]
  • 119. Jellinger KA, Bancher C (1996) Dementia with Lewy bodies: relationships to Parkinson's and Alzheimer's diseases. In: Dementia with Lewy Bodies, Perry RH, McKeith IGE.K.P, (Eds.), pp. 268–86, Cambridge University Press: Cambridge . [Google Scholar]
  • 120. Jendroska K, Lees AJ, Poewe W, Daniel SE (1996) Amyloid beta peptide and the dementia of Parkinson's disease. Mov Disord 11:647–53. [DOI] [PubMed] [Google Scholar]
  • 121. Joachim CL, Morris JH, Selkoe DJ (1988) Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 24:50–6. [DOI] [PubMed] [Google Scholar]
  • 122. Johnson WG, Hodge SE, Duvoisin R (1990) Twin studies and the genetics of Parkinson's disease ‐ a reappraisal. Mov Disord 5:240–8. [DOI] [PubMed] [Google Scholar]
  • 123. Kalyanasundaram S, Srivinas HV, Deshpande DH (1980) An adult with Hallervorden‐Spatz disease: Clinical and pathological study. Clin Neurol Neurosurg 82:245–9. [DOI] [PubMed] [Google Scholar]
  • 124. Kamboh Ml, Sanghera DK, Ferrell RE, de Kosky S (1995) APOE 4‐associated Alzheimer's disease risk is modified by a1‐antichymotrypsin polymorphism. Nature Genet 10:486–8. [DOI] [PubMed] [Google Scholar]
  • 125. Katzman R, Galasko D, Saitoh T, Thai LJ, Hansen L (1995) Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cognition 28:259–65. [DOI] [PubMed] [Google Scholar]
  • 126. Kawanishi C, Suzuki K, Odawara T, Iseki E, Onishi H, Miyakawa T, Yamada Y, Kosaka K (1996) Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 136:140–2. [DOI] [PubMed] [Google Scholar]
  • 127. Khachaturian ZS (1985) The diagnosis of Alzheimer's disease. Arch Neurol 42:1097–105. [DOI] [PubMed] [Google Scholar]
  • 128. Kim H, Gearing M, Mirra SS (1995) Ubiquitin‐positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45:1768–70. [DOI] [PubMed] [Google Scholar]
  • 129. Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathological study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 47:1148–52. [DOI] [PubMed] [Google Scholar]
  • 130. Koller WC, Glatt SL, Hubble JP, Paolo A, Troster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A, Wijsman EM, Yu C‐E, Schellenberg GD (1995) Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 37:242–5. [DOI] [PubMed] [Google Scholar]
  • 131. Kosaka K (1978) Lewy bodies in the cerebral cortex. Report of three cases. Acta Neuropathol 42:127–34. [DOI] [PubMed] [Google Scholar]
  • 132. Kosaka K (1993) Dementia and neuropathology in Lewy body disease. Adv Neurol 60:456–63. [PubMed] [Google Scholar]
  • 133. Kosaka K, Iseki E (1996) Diffuse Lewy body disease within the spectrum of Lewy body disease. In: Dementia with Lewy Bodies, Perry RH, McKeith IG, Perry EK, (Eds.), pp. 238–47, Cambridge Universtity Press: Cambridge . [Google Scholar]
  • 134. Kosaka K, Iseki E, Odawara T, et al. (1996) Cerebral type of Lewy body disease. Neuropathol 16:32–5. [Google Scholar]
  • 135. Kosaka K, Matsushita M, Oyanagi S, Mehraein P (1980) A clinicopathological study of the ‘Lewy Body Disease. Pschiatr Neurol Japon 82:292–311. [PubMed] [Google Scholar]
  • 136. Kosaka K, Mehraein P (1979) Dementia‐parkinsonism with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nevenkr 226:241–50. [DOI] [PubMed] [Google Scholar]
  • 137. Kosaka K, Tsuchiya K, Yoshimura M (1989) Lewy body disease with and without dementia: a clinicopathological study of 35 cases. Clin Neuropathol 7:299–305. [PubMed] [Google Scholar]
  • 138. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree ‐ A new disease Clin Neuropathol 3:1 85–92. [PubMed] [Google Scholar]
  • 139. Ince P. et al: Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome. [DOI] [PMC free article] [PubMed]
  • 139. Kosel S, Lucking CB, Egensperger R, Mehraein P, Graeber MB (1996) Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy‐body parkinsonism. J Neurosci Res 44:174–83. [DOI] [PubMed] [Google Scholar]
  • 140. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993) Association of monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33:368–72. [DOI] [PubMed] [Google Scholar]
  • 141. Kurth MC, Kurth JH (1993) Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease risk. Am J Med Genet 48:166–8. [DOI] [PubMed] [Google Scholar]
  • 142. Kuzuhara S, Yoshimura M, Mizutani T, Yamanouchi H, Ihara Y (1996) Temporal lobe immunohistochemical pathology for tangles, plaques and Lewy bodies in diffuse Lewy body disease, Parkinson's disease and senile dementia of Alzheimer type. In: Dementia with Lewy Bodies, Perry RH, McKeith IG, Perry RH, (Eds.), pp. 248–54, Cambridge University Press: Cambridge . [Google Scholar]
  • 143. Kwak S, Masaki T, Ishiura S, Sugita H (1991) Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in diffuse Lewy body disease brains. Neurosci Lett 128:21–4. [DOI] [PubMed] [Google Scholar]
  • 144. Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM (1998) Apolipoprotein E and alpha‐1 anti‐chymotrypsin polymorphism genotyping in Alzheimer's disease and Dementia with Lewy bodies: distinctions between diseases. Neurology in press:. [DOI] [PubMed] [Google Scholar]
  • 145. Landen M, Thorsell A, Wallin A, Blennow K (1996) The apolipoprotein E epsilon 4 allele does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosug Psychiatr 61:352–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146. Langlais PJ, Thai L, Hansen L, Galasko D, Alford M, Masliah E (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 43:1927–34. [DOI] [PubMed] [Google Scholar]
  • 147. Lantos PL, Ovenstone IM, Johnson J, Clelland CA, Roques P, Rossor MN (1994) Lewy bodies in the brains of two members of a family with the 717 (Val to lie) mutation of the amyloid precursor protein gene. Neurosci Lett 172:77–9. [DOI] [PubMed] [Google Scholar]
  • 148. Le Couteur DG, Leighton PW, McCann SJ, Pond SM (1997) Association of a polymorphism in the dopamine transporter gene with Parkinson's disease. Mov Disord 12:760–3. [DOI] [PubMed] [Google Scholar]
  • 149. Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN (1990) Cortical concentrations of corticotropin‐releasing factor and its receptor in Alzheimer type dementia and major depression. Biol Psychiat 28:603–8. [DOI] [PubMed] [Google Scholar]
  • 150. Lehmann DJ, Johnston C, Smith AD (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late onset confirmed Alzheimer's disease. Hum Mol Genet 6:1933–6. [DOI] [PubMed] [Google Scholar]
  • 151. Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ (1989) Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiat 52:67–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Lewy FH (1912) Paralysis agitans. I. Pathologische anatomie. In: Handbuch der Neurologie, Lewandowsky M, (Eds.), pp. 920–33, Springer: Berlin . [Google Scholar]
  • 153. Lippa CF, Pulaski‐Salo D, Dickson DW, Smith TW (1997) Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci 147:161–6. [DOI] [PubMed] [Google Scholar]
  • 154. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinico‐pathological study. Ann Neurol 35:81–8. [DOI] [PubMed] [Google Scholar]
  • 155. Louis ED, Klatka LA, Lui Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 48:376–80. [DOI] [PubMed] [Google Scholar]
  • 156. Lowe J, Blanchard A, Morrell K, others a (1988) Ubiqutin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease and Alzheimer's disease as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle and Mallories bodies in alcoholic liver disease. J Pathol 155:9–15. [DOI] [PubMed] [Google Scholar]
  • 157. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson K (1990) Ubiquitin carboxyl‐terminal hydrolase (PGP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153–60. [DOI] [PubMed] [Google Scholar]
  • 158. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, Mayer RJ (1992) Alpha B crystallin expression in non‐lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166:61–8. [DOI] [PubMed] [Google Scholar]
  • 159. Lowe JS, Mayer RJ, Landon M (1996) Pathological significance of Lewy bodies in dementia. In: Dementia with Lewy bodies, Perry RH, McKeith IG, Perry EK, (Eds.), pp. 195–203, Cambridge University Press: Cambridge . [Google Scholar]
  • 160. Lucotte G, Turpin JC, Gerard N, Panserat S, Krishnamoorthy R (1996) Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson's disease patients and in families. Am J Med Genet 67:361–5. [DOI] [PubMed] [Google Scholar]
  • 161. Ma J, Yee A, Brewer BJ, Das S, Potter H (1994) Amyloid associated proteins a‐1 antichymotrypsin and apolipoprotein E promote assembly of Alzheimer b‐protein into filaments. Nature 372:92–4. [DOI] [PubMed] [Google Scholar]
  • 162. Mancardi GI, Mandybur TI, Liwnicz BH (1982) Spongiform‐like changes in Alzheimer's disease. Acta Neuropathol 56:146–50. [DOI] [PubMed] [Google Scholar]
  • 163. Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R (1994) The apolipoprotein e4 allele in Parkinson's disease with and without dementia. Neurology 44:1330–1. [DOI] [PubMed] [Google Scholar]
  • 164. Mark MH, Sage Jl, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC (1994) Meige syndrome in the spectrum of Lewy body disease. Neurology 44:1432–6. [DOI] [PubMed] [Google Scholar]
  • 165. Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Lee VM, Hurtig H, Julien JP, Clark C (1995) Association of apolipoprotein epsilon 4 allele and neuropathological findings in patients with dementia. Acta Neuropathol 90:239–43. [DOI] [PubMed] [Google Scholar]
  • 166. Masaki T, Ishiura S, Sugita H, Kwak S (1994) Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies. J Neurol Sci 122:127–34. [DOI] [PubMed] [Google Scholar]
  • 167. Masliah E, Achim CL, Ge N, de Teresa R, Terry RD, Wiley CA (1991) Spectrum of human immunodeficiency virus‐associated neocortical damage. Ann Neurol 32:321–9. [DOI] [PubMed] [Google Scholar]
  • 168. Masliah E, Mallory M, de Teresa R, Alford M, Hansen LA (1993) Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 617:258–66. [DOI] [PubMed] [Google Scholar]
  • 169. Masliah E, Terry RD, Alford M, de Teresa R (1990) Quantitative immunocytochemistry of synaptophysin in human neocortex: An alternative method to estimate the density of presynaptic terminals in paraffin sections. J Histochem Cytochem 38:837–44. [DOI] [PubMed] [Google Scholar]
  • 170. Masliah E, Terry RD, Alford M, de Teresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysin‐like immunoreactivity in Alzheimer's disease. Am J Pathol 138:235–46. [PMC free article] [PubMed] [Google Scholar]
  • 171. Matsumine H, Saito M, Shimoda‐Matsubayashi S, Tanaka H, Ishikawa A, Nakagawa‐Hattori Y, Yokochi M, Kobayashi T, Igarashi S, Takano H, Sanpei K, Koike R, Mori H, Kondo T, Mizutani Y, Schaffer AA, Yamamura Y, Nakamura S, Kuzahara S, Tsuji S, Mizuno Y (1997) Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2–27. Am J Hum Genet 60:588–96. [PMC free article] [PubMed] [Google Scholar]
  • 172. Mayeux R, Chen J, Mirabello E, et al (1990) An estimate of the incidence of dementia in patients with idiopathic Parkinson's disease. Neurology 40:1513–7. [DOI] [PubMed] [Google Scholar]
  • 173. Mayeux R, Ottman R, Tang M‐X, Noboa‐Bauza L, Marder K, Gurland B, Stern Y (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community dwelling elderly persons and their first degree relatives. Ann Neurol 33:494–501. [DOI] [PubMed] [Google Scholar]
  • 174. McKeith IG, Fairbairn A, Perry RH, Thompson P, Perry EK (1992) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Brit Med J 305:673–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175. McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, P. T. Perry RH (1994) An evaluation of the predictive value and inter‐rater reliability of clinical diagnositic criteria for senile dementia of Lewy body type. Neurology 44:872–7. [DOI] [PubMed] [Google Scholar]
  • 176. McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type. Br J Psychiatr 165:324–32. [DOI] [PubMed] [Google Scholar]
  • 177. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Loveston S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 47:1113–24. [DOI] [PubMed] [Google Scholar]
  • 178. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of Lewy body type. Psychol Med 22:911–22. [DOI] [PubMed] [Google Scholar]
  • 179. McKenzie JE, Edwards RJ, Gentleman SM, Ince PG, Perry RH, Royston MC, Roberts GW (1996) A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathol 91:526–9. [DOI] [PubMed] [Google Scholar]
  • 180. McShane R, Gedling K, Reading M, McDonald B, Esiri MM, Hope T (1995) Prospective study of relations between cortical Lewy bodies poor eyesight and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatr 59:185–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings JL (1996) Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. Neurology 47:1403–9. [DOI] [PubMed] [Google Scholar]
  • 182. Mirra SS, Hart M, Terry RD (1993) Making a diagnosis of Alzheimer's disease: a primer for the practicing pathologist. Arch Path Lab Med 117:132–44. [PubMed] [Google Scholar]
  • 183. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and participating CERAD neuropathologists (1991) The consortium to establish a registry of Alzheimer's disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–86. [DOI] [PubMed] [Google Scholar]
  • 184. Monaco S, Nardelli E, Moretto G, Cavallaro T, Rizzuto N (1988) Cytoskeletal pathology in ataxia telangiectasia. Clin Neuropathol 7:44–5. [PubMed] [Google Scholar]
  • 185. Mori H, Yoshimura M, Tomonaga M, Yamanouchi H (1986) Progressive supranuclear palsy with Lewy bodies. Acta Neuropathol 71:344–6. [DOI] [PubMed] [Google Scholar]
  • 186. Morin P, Lechavelier B, Bianco C (1980) Cerebellar atrophy associated with lesions of the pallidum and Luys body and the presence of Lewy bodies. Relationships with degenerative disorders of the pallidum, substantia nigra and Luys’ body. Rev Neurol 136:381–90. [PubMed] [Google Scholar]
  • 187. Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, Brown A, Ince PG, Tyrer S, Thompson P, McKeith IG, Edwardson JA, Perry RH, Perry EK (1996) Molecular biology of APO E alleles in Alzheimer's disease and non‐Alzheimer's dementias. J Neural Trans 47 (Suppl):205–18. [DOI] [PubMed] [Google Scholar]
  • 188. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM‐F, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56:165–70. [DOI] [PubMed] [Google Scholar]
  • 189. Nagy ZS, Esiri MM, Jobst KA, Johnston I, Litchfield S, Sim E, Smith AD (1995) Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neurosci 69:757–61. [DOI] [PubMed] [Google Scholar]
  • 190. Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J (1997) p35nck5a and cyclin‐dependent kinase 5 colocalise in lewy bodies in brains with Parkinson's disease. Acta Neuropathol 94:153–7. [DOI] [PubMed] [Google Scholar]
  • 191. Nanko S, Ueki A, Hattori M (1996) No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. Neurosci Lett 204:. [DOI] [PubMed] [Google Scholar]
  • 192. Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H (1994) No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. Am J Med Genet 54:361–4. [DOI] [PubMed] [Google Scholar]
  • 193. National Institue on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18 (Suppl):S1–2. [PubMed] [Google Scholar]
  • 194. Nishimura M, Tomimoto H, Suenaga T, Nakamura S, Namba Y, Ikeda K, Akiguchi I, Kimura J (1994) Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease. Brain Res 634:339–44. [DOI] [PubMed] [Google Scholar]
  • 195. Nishiyama K, Murayama S, Shimizu J, Ohya Y, Kwak S, Asayama K, Kanazawa I (1995) Cu/Zn superoxide dismutase‐like immunoreactivity is present in Lewy bodies from Parkinson's disease: a light and electron microscopic immunocytochemical study. Acta Neuropathol 89:471–4. [DOI] [PubMed] [Google Scholar]
  • 196. Nussbaum RL, Polymeropoulos MH (1997) Genetics of Parkinson's disease. Hum Mol Genet 6:1687–91. [DOI] [PubMed] [Google Scholar]
  • 197. Ohm TG, Kirca M, Bohl J, Scharnagl H, Gross W, Marz W (1995) Apolipoprotein E polymorhism influences not only cerebral senile plaque load but also Alzheimer‐type neurofibrillary tangle formation. Neurosci 66:583–7. [DOI] [PubMed] [Google Scholar]
  • 198. Okazaki H, Lipkin LS, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 20:237–44. [DOI] [PubMed] [Google Scholar]
  • 199. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurol 47:190–6. [DOI] [PubMed] [Google Scholar]
  • 200. Paulus W, Selim M (1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 81:89–94. [DOI] [PubMed] [Google Scholar]
  • 201. Pellise A, Roig C, Barraquer‐Bordas LI, Ferrer I (1996) Abnormal ubiquitinated cortical neurites in patients with diffuse Lewy body disease. Neurosci Lett 206:85–8. [DOI] [PubMed] [Google Scholar]
  • 202. Pericak‐Vance MA, Bass MP Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL (1997) Complete genomic screen in late onset Alzheimer's disease. Evidence for a new locus on chromosome 12. JAMA 278:1237–41. [PubMed] [Google Scholar]
  • 203. Perry EK, Ballard C, Spurden D, Cheng AV, Johnson M, McKeith IG, Piggott M, Perry RH (1998) Cholinergic systems in the human brain: psychopharmacology and psychosis. Alz Dis Rev (in press). [Google Scholar]
  • 204. Perry EK, Court JA, Goodchild R, Griffiths M, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C, Jaros E, McKeith IG, Ince PG, Perry RH (1998) Clinical neuro‐chemistry: developments in dementia research based on brain bank material. J Neural Trans (in press). [DOI] [PubMed] [Google Scholar]
  • 205. Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Mrinalini H, Dean A, Griffiths M, McKeith IG, Perry RH (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 5:747–9. [DOI] [PubMed] [Google Scholar]
  • 206. Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH (1990) Evidence of a monoaminergic:cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 55:1544–6. [DOI] [PubMed] [Google Scholar]
  • 207. Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF (1990) Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alz Dis Assoc Disord 4:87–95. [PubMed] [Google Scholar]
  • 208. Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, Irving D, Perry RH (1993) Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. J Neural Trans 6:167–77. [DOI] [PubMed] [Google Scholar]
  • 209. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neurosci 64:385–95. [DOI] [PubMed] [Google Scholar]
  • 210. Perry EK, Perry RH (1995) Acetylcholine and hallucinations: disease‐related compared with drug‐induced alterations in human consciousness. Brain Cognition 28:240–58. [DOI] [PubMed] [Google Scholar]
  • 211. Perry EK, Smith CJ, Court JA, Perry RH (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Trans 2:149–58. [DOI] [PubMed] [Google Scholar]
  • 212. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type: a clinically and neuropatholgically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95:119–39. [DOI] [PubMed] [Google Scholar]
  • 213. Piggott MA, Perry RH, McKeith IG, Marshall E, Perry EK (1994) Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity. Lancet 343:1044–5. [PubMed] [Google Scholar]
  • 214. Plante‐Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE (1994) Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatr 57:911–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215. Plante‐Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD, Harding AE (1997) Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence of association of a DRD2 allele. Neurology 48:1589–93. [DOI] [PubMed] [Google Scholar]
  • 216. Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand D, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697–9. [DOI] [PubMed] [Google Scholar]
  • 217. Pollanen MS, Bergeron C, Weyer L (1992) Detergent insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau. J Neurochem 58:1953–6. [DOI] [PubMed] [Google Scholar]
  • 218. Pollanen MS, Bergeron C, Weyer L (1993) Deposition of detergent‐resistant neurofilaments into Lewy body fibrils. Brain Res 603:121–4. [DOI] [PubMed] [Google Scholar]
  • 219. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183–91. [DOI] [PubMed] [Google Scholar]
  • 220. Pollanen MS, Markiewicz P, Weyer L, Goh MC, Bergeron C (1994) Mallory body filaments become insoluble after normal assembly into intermediate filaments. Am J Pathol 145:140–7. [PMC free article] [PubMed] [Google Scholar]
  • 221. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkoniemi A, Niinistu L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of beta amyloid protein. New Eng J Med 333:1242–7. [DOI] [PubMed] [Google Scholar]
  • 222. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Lorio G, Golbe LI, Nussbaum RL (1997) Mutation in the a‐synuclein gene identified in families with Parkinson's disease. Science 276:2045–7. [DOI] [PubMed] [Google Scholar]
  • 223. Raghavan R, Khin‐Nu C, Brown A, Irving D, Ince PG, Day K, Tyrer SP, Perry RH (1993) Detection of Lewy bodies in trisomy 21 (Down's syndrome). Can J Neurol Sc; 20:48–51. [DOI] [PubMed] [Google Scholar]
  • 224. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575–80. [DOI] [PubMed] [Google Scholar]
  • 225. Rezaie P, Cairns NJ, Chadwick A, Lantos PL (1996) Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett 212:111–4. [DOI] [PubMed] [Google Scholar]
  • 226. Sahgal A, Galloway PH, McKeith IG, et al (1992) Matching‐to‐sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol 49:1043–6. [DOI] [PubMed] [Google Scholar]
  • 227. Sahgal A, Gallowy PH, McKeith IG, Edwardson JA, Lloyd S (1992) A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 3:350–4. [DOI] [PubMed] [Google Scholar]
  • 228. Sahgal A, McKeith IG, Galloway PH, Tasker N, Steckler T (1995) Do differences in visuospatial ability between senile dementia of the Alzheimer and Lewy body types reflect differences solely in mnemonic function. J Clin Exp Neuropsychol 17:35–43. [DOI] [PubMed] [Google Scholar]
  • 229. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thai LJ, Hansen LA, Katzman R (1995) The CYP2D6B mutant allele is overepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 37:110–2. [DOI] [PubMed] [Google Scholar]
  • 230. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thai LJ, Katzman R (1996) Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cognition 31:148–65. [DOI] [PubMed] [Google Scholar]
  • 231. Samuel W, Alford M, Hofstetter CR, Hansen L (1997) Dementia with Lewy bodies versus pure Alzheimer's disease: differences in cognition, neuropathology, cholinergic dysfunction, and synaptic density. J Neuropathol Exp Neurol 56:499–508. [DOI] [PubMed] [Google Scholar]
  • 232. Samuel W, Crowder R, Hofstetter CR, Hansen L (1997) Neuritic plaques in the Lewy body variant of Alzheimer's disease lack paired helical filaments. Neurosci Lett 223:73–6. [DOI] [PubMed] [Google Scholar]
  • 233. Samuel W, Galasko D, Masliah E, Hansen LA (1996) Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 55:44–52. [DOI] [PubMed] [Google Scholar]
  • 234. Sanan DA, Weisgraber KH, Russel SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with b‐amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform Apo E4 associates more efficiently than Apo E3. J Clin Invest 94:860–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 235. Saunders AM, Strittmatter WJ, Schmechel D, George Hyslop PH St, Pericak‐ Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper‐MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele 4 with late onset familial and sporadic Alzheimer's disease. Neurology 43:1467–72. [DOI] [PubMed] [Google Scholar]
  • 236. Schapira AH (1995) Oxidative stress in Parkinson's disease. Neuropathol Appl Neurobiol 21:3–9. [DOI] [PubMed] [Google Scholar]
  • 237. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE (1997) Huntingtin‐encoded polyglutamine expansions form amyloid‐like protein aggregates in vitro and in vivo. Cell 90:549–58. [DOI] [PubMed] [Google Scholar]
  • 238. Schmechel DE, Saunders AM, Strittmatter WJ, Crain B, Hulette CM, Joo SH, Pericak‐Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid b‐peptide deposition as a consequence of apolipoprotein E genotype in late onset Alzheimer's disease. Proc Natl Acad Sci USA 90:9649–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 239. Schmidt ML, Martin JA, Lee VM‐Y, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 91:475–81. [DOI] [PubMed] [Google Scholar]
  • 240. Schmidt ML, Murray JM, Lee VM‐Y, Hill WD, Wertkin A, Trojanowski JQ (1991) Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 139:53–65. [PMC free article] [PubMed] [Google Scholar]
  • 241. Schnopp NM, Kosel S, Egensperger R, Graeber MB (1996) Regional heterogeneity of mtDNA heteroplasmy in Parkinsonian brain. Clin Neuropathol 15:348–52. [PubMed] [Google Scholar]
  • 242. Scott WK, Yamaoka LH, Locke PA, Rosi BL, Gaskell PC, Saunders AM, Conneally PM, Small GW, Farrer LA, Growdon JH, Roses AD, Pericak‐Vance MA, Haines JL (1997) No association or linkage between an intronic polymorphism of presenilin‐1 and sporadic or late onset familial Alzheimer's disease. Genet Epidemiol 14:307–15. [DOI] [PubMed] [Google Scholar]
  • 243. Sima AA, Hoag G, Rozdilsky B (1987) Shy‐Drager syndrome: the transitional variant. Clin Neuropathol 6:49–54. [PubMed] [Google Scholar]
  • 244. Sima AAF, Clark AW, Sternberger NA, Sternberger LA (1986) Lewy body dementia without Alzheimer changes. Can J Neurol Sci 13:490–7. [DOI] [PubMed] [Google Scholar]
  • 245. Singleton AB, Atkinson AM, Gibson AM, Daly AK, Morris CM (1997) Association between PS‐2 polymorphism and Alzheimer's disease. Lancet 350:336–7. [DOI] [PubMed] [Google Scholar]
  • 246. Singleton AB, Lamb H, Leake A, McKeith IG, Ince PG, Perry R, Morris CM (1997) No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies. Neurorep 8:3637–9. [DOI] [PubMed] [Google Scholar]
  • 247. Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM (1997) No association between an intronic polymorphism in the presenilin 1 gene and Alzheimer's disease. Neurosci Lett 234:19–22. [DOI] [PubMed] [Google Scholar]
  • 248. Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, Sturman SG, Schapira AH, Williams AC, Spurr NK, Wolff CR (1992) Debrisoquine hydroxylase gene polymorphism and susceptibilty to Parkinson's disease. Lancet 339:1375–7. [DOI] [PubMed] [Google Scholar]
  • 249. Smith MC, Mallory M, Hansen LA, Ge N, Masiah E (1995) Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuroreport 6:673–9. [DOI] [PubMed] [Google Scholar]
  • 250. Smith TW, Anwer U, de Girolami U, Drachman DA (1987) Vacuolar change in Alzheimer's disease. Arch Neurol 44:1225–8. [DOI] [PubMed] [Google Scholar]
  • 251. Sobel E, Louhija J, Sulkava R (1995) Lack of association of apolipoprotein E allele 4 with late onset Alzheimer's disease among Finnish centenarians. Neurology 45:903–7. [DOI] [PubMed] [Google Scholar]
  • 252. Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljarvi L, Talasniemi S, Ryynanen M, Riekkinen PS (1995) A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying the apolipoprotein e4 allele. Neurosci Lett 187:79–82. [DOI] [PubMed] [Google Scholar]
  • 253. Spillantini MG, Schmidt ML, Lee VM‐Y, Trojanowski JQ, Jakes R, Goedert M (1997) a‐Synuclein in Lewy bodies. Nature 388:839–40. [DOI] [PubMed] [Google Scholar]
  • 254. Strittmatter WJ, Saunders AM, Schmechel D, Pericak‐Vance AM, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to b‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 255. Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S (1995) Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer's disease: evidence that the disorders are distinct. Alz Dis Assoc Disord 9:21–222. [PubMed] [Google Scholar]
  • 256. Sugiyama H, Hainfeller JA, Schmid SB, Budka H (1993) Neuraxonal dystrophy combined with diffuse Lewy body disease in a young adult. Clin Neuropathol 12:147–52. [PubMed] [Google Scholar]
  • 257. Sugiyama H, Hainfellner JA, Yoshimura M, Budka H (1994) Neocortical changes in Parkinson's disease, revisited. Clin Neuropathol 13:55–9. [PubMed] [Google Scholar]
  • 258. Tolnay M, Probst A (1995) Frontal lobe degeneration: Novel ubiquitin‐immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492–7. [DOI] [PubMed] [Google Scholar]
  • 259. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:205–42. [DOI] [PubMed] [Google Scholar]
  • 260. Tompkins MM, Basgall EJ, Zamrini E, Hill WD (1997) Apoptotic‐like changes in Lewy‐body‐associated disorders and normal aging in substantia nigral neurons. Am J Pathol 150:119–31. [PMC free article] [PubMed] [Google Scholar]
  • 261. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 262. Vieregge P (1994) Genetic factors in the etiology of idiopathic Parkinson's disease. J Neural Trans 8:1–37. [DOI] [PubMed] [Google Scholar]
  • 263. Vierrege P, Schiffke KA, Freidrich HJ, Muller B, Ludin HP (1992) Parkinson's disease in twins. Neurology 42:1453–61. [DOI] [PubMed] [Google Scholar]
  • 264. Vuia O (1977) Neuraxonal dystrophy: a juvenile adult form. Clin Neurol Neurosurg 79:305–15. [PubMed] [Google Scholar]
  • 265. Wakabayashi K, Hansen LA, Masliah E (1995) Cortical Lewy body‐containing neurons are pyramidal cells: laser scanning confocal imaging of double‐immunolabelled sections with anti‐ubiquitin. Acta Neuropathol 89:404–8. [DOI] [PubMed] [Google Scholar]
  • 266. Wakabayashi K, Hansen LA, Vincent I, Mallory M, Masliah E (1997) Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer's disease, Lewy body disease and progressive supranuclear palsy. Acta Neuropathol 93:7–12. [DOI] [PubMed] [Google Scholar]
  • 267. Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampal‐entorhinal formation in Alzheimer's disease with and without Lewy bodies. Brain Res 667:24–32. [DOI] [PubMed] [Google Scholar]
  • 268. Wakabayashi K, Oyanagi K, Makifuchi T, et al. (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87:545–53. [DOI] [PubMed] [Google Scholar]
  • 269. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson's disease: an immunohistochemical study of Lewy body‐containing neurons in the enteric nervous system. Acta Neuropathol 79:581–3. [DOI] [PubMed] [Google Scholar]
  • 270. Walker Z, Costa DC, Janssen AG, Walker RW, Livingstone G, Katona CL (1997) Dementia with Lewy bodies: a study of post‐synaptic dopaminergic receptors with iodine‐123 iodobenzamide single photon emission tomogtraphy. Eur J Nucl Med 24:609–14. [DOI] [PubMed] [Google Scholar]
  • 271. Wilhelmsen K, Mirel D, Marder K, Bernstein M, Naini A, Leal SM, Cote LJ, Tang MX, Freyer G, Graziano J, Mayeux R (1997) Is there a genetic susceptibility locus for Parkinson's disease on chromosome 22q13 Ann Neurol 41:813–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272. Williams T, Shaw PJ, Lowe J, Bates D, Ince PG (1995) Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 89:275–83. [DOI] [PubMed] [Google Scholar]
  • 273. Williamson K, Sima A, Curry B, Ludwin S (1982) Neuraxonal dystrophy in young adults: a clinicopathological study of two unrelated cases. Ann Neurol 11:335–43. [DOI] [PubMed] [Google Scholar]
  • 274. Wragg M, Hutton M, Talbot C, Alzheimer's Disease Collaborative Group (1996) Genetic association between intronic polymorphism in presenilin‐1 gene and late onset Alzheimer's disease. Lancet 347:509–12. [DOI] [PubMed] [Google Scholar]
  • 275. Xia Y, Rohan de Silva HA, Rosi BL, Yamaoka LH, Rimmler JB, Pericak‐Vance MA, Roses AD, Chen X, Masliah E, DeTeresa R, Iwai A, Sundsmo M, Thomas RG, Hofstetter CR, Gregory E, Hansen LA, Katzman R, Thai LJ, Saitoh T (1996) Genetic studies of Alzheimer's disease with an NACP/alpha‐synuclein polymorphism. Ann Neurol 40:207–15. [DOI] [PubMed] [Google Scholar]
  • 276. Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of ‘diffuse Lewy body disease. J Neurol 229:17–32. [DOI] [PubMed] [Google Scholar]
  • 277. Zhan S‐S, Beyreuther K, Schmitt HP (1994) Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. Dementia 5:79–87. [DOI] [PubMed] [Google Scholar]
  • 278. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson's disease. Neurology 43:986–91. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES